• Like
  • 1
  • Favorite

Tonix Pharmaceuticals Shares Down 20%, Company Plans Another Reverse Stock Split

Dow Jones2023-05-10

By Josh Beckerman

 

Shares of Tonix Pharmaceuticals Holding fell 20% to 41 cents on Tuesday after the company said it would conduct its second reverse stock split in less than a year.

The shares approaching their 52-week low of 29 cents and have fallen 90% in the last 12 months.

The biopharmaceutical company said a 1-for-6.25 reverse split will be effective for trading purposes on Wednesday. The move is intended to increase the per-share trading price to meet Nasdaq's $1 minimum bid price requirement.

The company completed a 1-for-32 reverse split effective on May 17, 2022.

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

May 09, 2023 13:43 ET (17:43 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment1

  • Aidukas
    ·2023-05-10
    THIEVES
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial